> ## Content Index > Fetch the complete content index at: https://www.missionviewpoint.com/llms.txt > Use this file to discover other available public pages before exploring further. # ABA's Missing Mergers - URL: https://www.missionviewpoint.com/abas-missing-mergers/ - Published: 2026-10-15T17:23:27.000Z - Updated: 2026-10-15T18:38:30.000Z - Author: Scott Dickson - Tags: Investor Briefings, Market Outlook, Provider: Action Behavior Centers, Provider: ACES *Part One of MissionViewpoint's series: Where Capital Is Betting on ABA* ABA looks like a market that **should be consolidating**. It's highly **fragmented**, demand for services continues to **grow,** and many of its largest providers have spent **years investing** in the technology, people, and processes needed to **operate at scale**. After a **decade of private equity investment**, you might expect the largest organizations to be acquiring smaller competitors and **increasingly combining with one another**. > But that isn't quite what's happening. As part of MissionViewpoint's ongoing tracking of the ABA provider market, I've been looking at acquisition activity among the 35 largest organizations. There have been acquisitions, **primarily smaller regional providers** joining larger organizations. What I haven't identified in more than two years **is a combination between two Top 35 providers**. Financial ownership has changed. Several large providers have been sold to new investors, but those transactions **don't necessarily combine care delivery operations**. ***Recapitalizing*** a provider and ***acquiring*** another provider to integrate into an existing organization are **two very different propositions**. Meanwhile, the **largest ABA providers continue to grow**. The more interesting question may be why so much of that growth appears to be coming from **de novo expansion** rather than **acquisitions**. I suspect the answer has as much to do with technology, data, and operational **complexity** as it does with the availability of capital. ## Growth Without Consolidation For nearly two years, I've tracked LinkedIn employment patterns across ABA providers through [MissionViewpoint SCUBA](https://www.missionviewpoint.com/tag/provider-scuba/) — Scott's Completely Unscientific Behaviorist Assessment. SCUBA isn't a measure of actual employment, profitability, or acquisitions. But it offers a consistent directional view of staffing momentum across the industry. The picture in 2026 has been one of **continued expansion**. The Top 20 providers added approximately 3% in LinkedIn headcount during the third quarter, with 18 finishing September above their June levels. Across a broader group of 166 providers, **more than half increased headcount in September**, even as the number showing declines began to rise. That doesn't suggest widespread contraction. Providers are **still growing**, even if some are becoming more cautious. **But growth doesn't have to come from acquisitions.** [Action Behavior Centers](https://www.missionviewpoint.com/provider-profile-action-behavior-centers/) offers a useful example. It has grown from a handful of Texas clinics in 2018 to **more than 400 centers nationwide**, largely through *de novo* development. Its recent move toward **standardized center design** reflects an approach built around **replicating** an established operating model rather than integrating different ones. **The operational distinction matters.** When a provider opens another center, it **can extend** the clinical standards, technology, staffing processes, and reporting structures it already uses. It still has to recruit, establish referral relationships, secure payor participation, and build utilization. **But it isn't starting with someone else's operating history**. An acquisition offers immediate capacity and an established workforce, but it also brings another organization's systems, processes, contracts, and data. **And those are not always easy to combine.** ## The Risk You Acquire Along With the Provider The financial case for acquiring an ABA provider depends on something deceptively simple: **confidence** that the business will **continue producing** the revenue and margins reflected in its **historical performance**. That confidence **has become harder** to establish. In February, I wrote about the underlying problem in the context of the [Magellan/Centene](https://www.missionviewpoint.com/when-integration-fails-to-tame-behavioral-risk/) divestiture. ABA still lacks a broadly accepted framework of outcome measures that providers and payors consistently use to evaluate the value of care relative to its cost. Without that foundation, payors continue to manage spending through **authorization requirements, utilization controls, documentation reviews,** and **retrospective audits.** For providers, those requirements create administrative work. For an acquirer, they **create uncertainty** about the **future economics** of the business being purchased. A provider may have strong referral demand, growing staffing, and several years of increasing revenue. But how much of that revenue depends on authorization patterns **that could change**? How **consistently** are services documented? How much of the reported revenue has actually been **collected**? And how much of what has been collected remains subject to **retrospective review**? These are financial questions, but answering them **depends heavily** on **operational data**. A **prospective buyer needs to understand** the relationship between authorized hours, scheduled hours, delivered services, documented sessions, submitted claims, and collected revenue. Those measures **may exist across several systems,** with different definitions and varying levels of reliability. A financial statement can show what happened. It doesn't necessarily explain **how reliably the organization can reproduce those results**. Then there is the possibility that historical revenue **isn't entirely settled**. Retrospective payor **audits** and **clawbacks** can turn documentation deficiencies, billing errors, or disagreements over medical necessity into demands to **return payments** for services delivered months or years earlier. Transaction protections can allocate some of that financial exposure, but they don't necessarily resolve the **underlying operational problems**. An acquirer may also inherit clinical practices or documentation patterns that create **reputational risk**. Discovering those problems after closing can mean **more than repaying claims**. It can require **rebuilding confidence** with families, clinicians, and payors. This is where **data quality** and **operational visibility** become particularly important. If an organization cannot reliably connect its clinical documentation to its billing history, **understanding the risk** embedded in years of delivered services becomes considerably more **difficult**. The buyer isn't simply acquiring revenue. **It's acquiring the processes and evidence supporting that revenue.** ## Integration Is More Than Combining Organizations Even when the financial and compliance risks are manageable, there's another challenge: **integrating the acquired business**. An acquisition can bring a **different** clinical model, scheduling process, practice management system, payroll structure, billing operation, and set of performance measures. The acquiring organization must decide which practices to **retain**, which to **replace**, and how to bring the combined business under **consistent operational control**. That's a substantial **change management** exercise. Earlier this year, [ACES](https://www.missionviewpoint.com/provider-profile-aces/) acquired Ally Pediatric Therapy and announced plans to **wind down** the acquired organization's speech, occupational therapy, and feeding services to align with its ABA-focused model. That may be an **entirely sensible strategic decision**. But it illustrates that acquiring an organization doesn't necessarily mean preserving how it operates. Sometimes the acquisition is followed by rebuilding significant portions of the business around the buyer's existing model. > Technology can make that considerably harder. I've written extensively about why large ABA providers are[ reluctant to replace their practice management platforms](https://www.missionviewpoint.com/almost-everyone-wants-to-switch-almost-no-one-does/). Even when a better alternative exists, the migration risk can outweigh the expected benefits. Scheduling, clinical documentation, authorizations, billing, reporting, and integrations all depend on systems that cannot simply be switched off. Now consider acquiring another provider operating on an entirely **different technology stack**. The buyer must decide whether to **migrate** the acquired organization, maintain multiple systems, or **build integrations** between them. Each choice has **costs** and **consequences**. Historical data may not transfer cleanly, reporting definitions may differ, and employees must adapt to unfamiliar workflows. And unlike a planned technology replacement, the acquisition may introduce all these challenges **alongside changes** in clinical leadership, organizational culture, and operating policies. The expected economies of scale don't materialize simply because two businesses share an owner. **They have to be created through integration.** That takes time, capital, and management **attention**. And in an industry already managing reimbursement uncertainty, the return on that effort may be **difficult to predict**. ## Why De Novo May Be Winning This helps explain the appeal of de novo expansion. Opening a new center **isn't necessarily cheaper or more profitable** than acquiring an established provider. New locations require upfront investment, recruiting, payor enrollment, referral development, and time to reach sustainable utilization. **Some will underperform**. But an organization with a proven operating model has a meaningful advantage: **it knows what it is trying to replicate.** The technology is already **selected**. Clinical documentation standards are **established**. Scheduling and billing processes are **defined**. Management knows which operating measures **matter** and how to **monitor** them. The organization can extend existing workflows, reporting, and oversight rather than spend months **reconciling a different set of practices.** That creates an opportunity to scale not just the number of locations, but the **consistency** of the operation. For a provider that has invested in its technology and operational infrastructure, each additional center can make better use of **capabilities already in place**. Centralized intake, scheduling support, revenue cycle management, recruiting, compliance, and analytics can serve more locations without requiring every new center to **build those functions independently**. The economics still have to work. But the organization is expanding a system it **understands** rather than paying to acquire one it may need to **substantially change.** This doesn't mean acquisitions no longer make sense. Buying an established provider can **accelerate** market entry, bring **experienced** clinicians, and provide **access** to referral relationships that might take years to develop. Nor is reimbursement uncertainty the **only reason** consolidation may be subdued. Existing owners may be **focused** on improving earlier acquisitions, financing may be more **difficult,** and buyers and sellers may disagree about **valuation.** But if de novo expansion is delivering acceptable growth with less integration complexity, the acquisition **has to offer something meaningfully better**. For some of the industry's largest providers, that hurdle may simply be getting **higher**. ## Capital Hasn't Disappeared None of this suggests investors have abandoned ABA. Financial ownership transactions continue, and some providers are still acquiring others. But the **limited number of combinations among the largest organizations** raises questions about how investors are evaluating the risks of expanding care delivery. Meanwhile, capital is finding **other opportunities** in the same industry. In September, Hi Rasmus announced a [$50 million minority investment](https://www.missionviewpoint.com/hi-rasmus-raises-50-million-what-kind-of-platform-is-it-becoming/) from Updata Partners to expand its ABA-focused clinical technology business. In October, Brellium announced another [$23 million](https://www.missionviewpoint.com/brelliums-23-million-bet-beyond-aba-without-leaving-it-behind/) to expand its AI-powered clinical compliance capabilities, including its work in ABA and other healthcare markets. Those investments **aren't equivalent** to acquiring providers. They involve ***different*** business models, growth expectations, and risks. But they point toward an interesting **distinction**. The operational complexity that can make acquiring an ABA provider difficult may **also create demand for better technology**. Organizations expanding through de novo development still need systems capable of supporting more locations, more employees, and increasingly complex operations. And the requirements for managing clinical quality, compliance, and reimbursement risk **aren't getting simpler.** Perhaps the more interesting question isn't why capital has stopped consolidating ABA providers. It's **where investors see opportunities** to support the organizations that are still growing. That's where the next part of this series begins. --- *Next in Where Capital Is Betting on ABA: Part Two — The Enterprise Platform Market May Finally Be Opening.*